Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.25 USD | +5.93% | +20.19% | +127.27% |
04-19 | Gilead Sciences Likely to Record IPR&D Hit on Q1 Non-GAAP Earnings, Oppenheimer Says | MT |
04-01 | Xilio Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
XILIO THERAPEUTICS, INC. | Other Biotechnology & Medical Research | +5.93% | +20.19% | +127.27% | -59.94% | - | 43.55M |
- Stock Market
- Equities
- XLO Stock
- Charts Xilio Therapeutics, Inc.
- Relative Strength Chart